- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Quipt Home Medical-Aktie erreicht 52-Wochen-Tief bei 2,55 US-Dollar | 2 | Investing.com Deutsch | ||
| Fr | Quipt Home Medical stock hits 52-week low at $2.55 | 2 | Investing.com | ||
| 05.09. | Quipt Home Medical stock hits 52-week low at $2.6 amid challenges | 1 | Investing.com | ||
| QUIPT HOME MEDICAL Aktie jetzt für 0€ handeln | |||||
| 21.08. | Quipt Home Medical stock target cut, maintains buy rating on revenue growth | 1 | Investing.com | ||
| 16.08. | Earnings call: Quipt Home Medical sees steady growth in Q3 2024 | 1 | Investing.com | ||
| 16.08. | Quipt shares target cut while maintaining buy rating | 1 | Investing.com | ||
| 15.08. | Quipt Home Medical stock hits 52-week low at $2.83 | 1 | Investing.com | ||
| 15.08. | Quipt Home Medical GAAP EPS of -$0.04 misses by $0.03, revenue of $64M misses by $0.84M | 1 | Seeking Alpha | ||
| 15.08. | Quipt Home Medical Corp.: Quipt Home Medical Reports Third Quarter Fiscal 2024 Financial Results | 130 | GlobeNewswire (Europe) | CINCINNATI, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT; TSX: QIPT), a U.S.-based home medical equipment provider, focused on end-to-end respiratory care... ► Artikel lesen | |
| 14.08. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 31.07. | Quipt Home Medical Corp: Quipt Home Medical to release Q3 2024 results Aug. 14 | 1 | Stockwatch | ||
| 31.07. | Quipt Home Medical Corp. to Announce Fiscal Third Quarter 2024 Financial Results on August 14, 2024 | 1 | GlobeNewswire (USA) | ||
| 18.07. | Quipt Home Medical a "Top Pick" at Ventum | 2 | Cantech Letter | ||
| 04.06. | Quipt Home Medical Corp. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 15.05. | Quipt Home Medical Corp.: Quipt Home Medical Reports Second Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 10% and Adjusted EBITDA Growth of 14% | 110 | GlobeNewswire (Europe) | • Posts Adjusted EBITDA Margin of 23.3% as a % of Revenue • Announced Normal Course Issuer Bid ("NCIB") Subsequent to Quarter End CINCINNATI, May 15, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp.... ► Artikel lesen | |
| 02.05. | Quipt Home Medical Corp.: Quipt Home Medical Announces Normal Course Issuer Bid | 170 | GlobeNewswire (Europe) | CINCINNATI, May 02, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT) (TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care... ► Artikel lesen | |
| 28.03. | Quipt Home Medical Corp.: Quipt Home Medical Announces Voting Results from Its Annual General and Special Meeting of Shareholders | 207 | GlobeNewswire (Europe) | CINCINNATI, March 28, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT) (TSX: QIPT)?, a U.S. based home medical equipment provider, focused on end-to-end respiratory... ► Artikel lesen | |
| 14.02. | Quipt Home Medical Corp.: Quipt Home Medical Reports Strong Operating Performance With Record First Quarter Fiscal 2024 Financial Results Posting Revenue Growth of 60% and Adjusted EBITDA Growth of 71% | 118 | GlobeNewswire (Europe) | CINCINNATI, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care... ► Artikel lesen | |
| 08.01. | Scrap to Stacked: Fixably and Quipt Turbocharge Pre-Owned Device Profits With AI-Powered Automation | 236 | ACCESSWIRE | HELSINKI, FINLAND / ACCESSWIRE / January 8, 2024 / Fixably, the leading global provider of repair and service management software, announced a strategic partnership with Quipt, the leading recommerce... ► Artikel lesen | |
| 18.12.23 | Quipt Home Medical Corp.: Quipt Home Medical Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results Posting Revenue Growth of 59% and Adjusted EBITDA Growth of 73% | 154 | GlobeNewswire (Europe) | CINCINNATI, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the "Company") (NASDAQ: QIPT; TSX: QIPT), a U.S. based home medical equipment provider, focused on end-to-end respiratory care... ► Artikel lesen |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| FRESENIUS MEDICAL CARE | 41,720 | +2,25 % | DZ BANK stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Halten' | FRANKFURT (dpa-AFX Analyser) - Die DZ Bank hat den fairen Wert für FMC von 37 auf 41 Euro angehoben und die Einstufung auf "Halten" belassen. Der Dialyseanbieter habe ein gelungenes Quartal hinter sich... ► Artikel lesen | |
| VITA 34 | 4,160 | 0,00 % | EQS-PVR: Vita 34 AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung | EQS Stimmrechtsmitteilung: Vita 34 AG
Vita 34 AG: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung
07.10.2024 / 15:01 CET/CEST
Veröffentlichung... ► Artikel lesen | |
| M1 KLINIKEN | 16,700 | -2,91 % | EQS-News: M1 Kliniken AG steigert operativen Gewinn (EBIT) um 71 % in den ersten neun Monaten 2024 und bestätigt Mittelfristziele | EQS-News: M1 Kliniken AG
/ Schlagwort(e): Quartalsergebnis/9-Monatszahlen
M1 Kliniken AG steigert operativen Gewinn (EBIT) um 71 % in den ersten neun Monaten 2024 und bestätigt... ► Artikel lesen | |
| BAXTER | 30,710 | -0,86 % | Baxter stock touches 52-week low at $32.4 amid market shifts | ||
| DAVITA | 153,95 | +0,52 % | DaVita-Aktie leicht im Minus (149,1616 €) | An der US-amerikanischen Börse notiert das Wertpapier von DaVita derzeit etwas leichter. Zuletzt zahlten Investoren für das Wertpapier 157,98 US-Dollar. Für der Anteilsschein von DaVita steht gegenwärtig... ► Artikel lesen | |
| EVOFEM BIOSCIENCES | - | - | Evofem Biosciences, Inc.: Evofem Biosciences Announces Financial Results for the Third Quarter of 2024 | - Improved loss from operations by 31% -
- Acquired SOLOSEC, a commercially attractive, single-dose oral antibiotic FDA-approved to treat two pervasive sexual health... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,010 | +2,02 % | Co-Diagnostics, Inc. Reports Third Quarter 2024 Financial Results | SALT LAKE CITY, Nov. 7, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| EMEIS | 5,705 | +1,44 % | emeis: Upturn in Performance Confirmed in Third-Quarter 2024 | Revenue up +8.3%, occupancy rate up +2.6 points
Regulatory News:
emeis (Paris:EMEIS):
Growth in all core activities and in all geographical areas (revenue and occupancy rate)
Solid... ► Artikel lesen | |
| CYTOSORBENTS | 0,877 | +0,46 % | CytoSorbents; Converge Biotech: CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India | PRINCETON, N.J. and HYDERABAD, India, Nov. 11, 2024 (GLOBE NEWSWIRE) -- CytoSorbents Corporation (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit... ► Artikel lesen | |
| SENSEONICS | 0,299 | -1,64 % | Senseonics Holdings, Inc. - 8-K, Current Report | ||
| NANO-X IMAGING | 5,890 | 0,00 % | Nano-X Imaging LTD.: Nanox Receives FDA Clearance for HealthCCSng V2.0, Upgraded Version of Advanced AI Cardiac Solution Empowering Physicians in Assessment of Coronary Artery Calcium | HealthCCSng V2.0 introduces additional 'zero calcium' categorization of coronary artery calcium (CAC) and generates a numerical calcium score with corresponding CAC detection category output Marks... ► Artikel lesen | |
| UNIVERSAL HEALTH SERVICES | 187,00 | -0,53 % | Universal Health Services declares $0.20 dividend | ||
| DELCATH SYSTEMS | 9,400 | +2,73 % | Delcath Systems Stock (NASDAQ:DCTH) Among the Best Multibagger Stock to Buy Heading into 2025 | ||
| VIROMED MEDICAL | 2,200 | +3,77 % | EQS-DD: Viromed Medical AG: Uwe Perbandt, Kauf | Meldung und öffentliche Bekanntgabe der Geschäfte von Personen, die Führungsaufgaben wahrnehmen, sowie in enger Beziehung zu ihnen stehenden Personen
15.11.2024 / 16:15... ► Artikel lesen | |
| INTERPACE BIOSCIENCES | 2,880 | 0,00 % | Interpace Biosciences, Inc.: Interpace Biosciences Announces Record Third Quarter 2024 Financial and Business Results | Q3 Revenue of $12.3 million; a $3.2M and 35% increase year-over-year Q3 Test volume up 26% year over year to record levels Q3 Cash collections of $11.3M; a $1.4M and 15% increase year-over-year Q3... ► Artikel lesen |
Das Unternehmen QUIPT HOME MEDICAL CORP kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 2,430 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu QUIPT HOME MEDICAL CORP finden Sie auf Wallstreet Online.
